References

Systematic review of the incidence of sudden cardiac death in the United States

10.1016/j.jacc.2010.09.064 · 2011 · External reference

Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia

2006 · External reference

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

10.1161/01.cir.103.2.196 · 2001 · External reference

Mechanisms of abnormal calcium homeostasis in mutations responsible for catecholaminergic polymorphic ventricular tachycardia

10.1161/01.res.0000258468.31815.42 · 2007 · External reference

Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases

10.1016/j.yjmcc.2013.03.005 · 2013 · External reference

Intra-sarcoplasmic reticulum Ca2+ oscillations are driven by dynamic regulation of ryanodine receptor function by luminal Ca2+ in cardiomyocytes

10.1113/jphysiol.2009.175547 · 2009 · External reference

Ryanodine receptor luminal Ca2+ regulation: swapping calsequestrin and channel isoforms

10.1016/j.bpj.2009.07.030 · 2009 · External reference

Regulation of ryanodine receptors by calsequestrin: effect of high luminal Ca2+ and phosphorylation

10.1529/biophysj.104.051441 · 2005 · External reference

Luminal Ca2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants

10.1085/jgp.200709907 · 2008 · External reference

Store-dependent deactivation: cooling the chain-reaction of myocardial calcium signaling

10.1016/j.yjmcc.2012.10.008 · 2013 · External reference

Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death

10.1161/01.res.0000220647.93982.08 · 2006 · External reference

New roles of calsequestrin and triadin in cardiac muscle

10.1113/jphysiol.2009.172098 · 2009 · External reference

Calsequestrin 2 deletion shortens the refractoriness of Ca2+ release and reduces rate-dependent Ca2+-alternans in intact mouse hearts

10.1016/j.yjmcc.2011.09.020 · 2012 · External reference

Decreased RyR2 refractoriness determines myocardial synchronization of aberrant Ca2+ release in a genetic model of arrhythmia

10.1073/pnas.1300052110 · 2013 · External reference

Molecular basis of catecholaminergic polymorphic ventricular tachycardia

10.1016/j.hrthm.2008.09.013 · 2009 · External reference

Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia

10.1161/circulationaha.106.623793 · 2006 · External reference

Update of the guidelines on sudden cardiac death of the European Society of Cardiology

10.1016/s0195-0668x(02)00809-6 · 2003 · External reference

β-adrenergic stimulation increases the intra-sarcoplasmic reticulum Ca2+ threshold for Ca2+ wave generation

10.1113/jphysiol.2012.236117 · 2012 · External reference

Role of RyR2 phosphorylation in heart failure and arrhythmias: controversies around ryanodine receptor phosphorylation in cardiac disease

10.1161/circresaha.114.300568 · 2014 · External reference

The Cardiac Arrhythmia Pilot Study

10.1016/0002-9149(86)90958-6 · 1986 · External reference

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

10.1016/j.jacc.2011.01.026 · 2011 · External reference

Power and pitfalls of using transgenic mice to optimize therapy for CPVT—a need for prospective placebo-controlled clinical trials in genetic arrhythmia disorders

10.1016/j.hrthm.2010.07.028 · 2010 · External reference

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

10.1038/nm.1942 · 2009 · External reference

Inhibition of Na+ channels ameliorates arrhythmias in a drug-induced model of Andersen-Tawil syndrome

10.1016/j.hrthm.2012.10.005 · 2013 · External reference

Flecainide reduces Ca(2+) spark and wave frequency via inhibition of the sarcolemmal sodium current

10.1093/cvr/cvt012 · 2013 · External reference

Neuronal Na+ channel blockade suppresses arrhythmogenic diastolic Ca2+ release

10.1093/cvr/cvu262 · 2015 · External reference

The binding of saxitoxin and tetrodotoxin to excitable tissue

10.1007/bfb0037088 · 1977 · External reference

The Na+ channel in mammalian cardiac cells. Two kinds of tetrodotoxin receptors in rat heart membranes

10.1016/s0021-9258(18)32127-6 · 1983 · External reference

A mutant of TTX-resistant cardiac sodium channels with TTX-sensitive properties

10.1126/science.256.5060.1202 · 1992 · External reference

Distinct subcellular localization of different sodium channel alpha and beta subunits in single ventricular myocytes from mouse heart

10.1161/01.cir.0000121421.61896.24 · 2004 · External reference

Localization of sodium channel subtypes in mouse ventricular myocytes using quantitative immunocytochemistry

10.1016/j.yjmcc.2013.08.004 · 2013 · External reference

Subcellular heterogeneity of sodium current properties in adult cardiac ventricular myocytes

10.1016/j.hrthm.2011.07.016 · 2011 · External reference

Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model

10.1161/circresaha.108.171660 · 2008 · External reference

Alternating membrane potential/calcium interplay underlies repetitive focal activity in a genetic model of calcium-dependent atrial arrhythmias

10.1113/jphysiol.2014.280784 · 2015 · External reference

Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy

10.1152/ajpheart.00428.2004 · 2004 · External reference

Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure

10.1161/circulationaha.110.982298 · 2010 · External reference

Cx43 associates with Na(v)1.5 in the cardiomyocyte perinexus

10.1007/s00232-012-9465-z · 2012 · External reference

The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse

10.1073/pnas.1108586108 · 2011 · External reference

Genetic ablation of ryanodine receptor 2 phosphorylation at Ser-2808 aggravates Ca(2+)-dependent cardiomyopathy by exacerbating diastolic Ca2+ release

10.1113/jphysiol.2013.264689 · 2014 · External reference

Voltage-gated sodium channel isoform-specific effects of pompilidotoxins

10.1111/j.1742-4658.2009.07533.x · 2010 · External reference

A β(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice

10.1172/jci43621 · 2010 · External reference

Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites

10.1074/jbc.m111.322537 · 2012 · External reference

Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger

10.1073/pnas.0402765101 · 2004 · External reference

In silico docking reveals possible Riluzole binding sites on Nav1.6 sodium channel: implications for amyotrophic lateral sclerosis therapy

10.1016/j.jtbi.2012.09.004 · 2012 · External reference

μ-conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve

10.1073/pnas.1107027108 · 2011 · External reference

The TTX metabolite 4,9-anhydro-TTX is a highly specific blocker of the Na(v1.6) voltage-dependent sodium channel

10.1152/ajpcell.00070.2007 · 2007 · External reference

Evidence for a role of Nav1.6 in facilitating increases in neuronal hyperexcitability during epileptogenesis

10.1152/jn.00383.2013 · 2013 · External reference

Combined Na(+)/Ca(2+) exchanger and L-type calcium channel block as a potential strategy to suppress arrhythmias and maintain ventricular function

10.1161/circep.113.000322 · 2013 · External reference

Scn1b deletion leads to increased tetrodotoxin-sensitive sodium current, altered intracellular calcium homeostasis and arrhythmias in murine hearts

10.1113/jphysiol.2014.277699 · 2015 · External reference

Contribution of sodium channel neuronal isoform Nav1.1 to late sodium current in ventricular myocytes from failing hearts

10.1113/jphysiol.2014.278259 · 2015 · External reference

Prolongation of action potential duration and QT interval during epilepsy linked to increased contribution of neuronal sodium channels to cardiac late Na+ current: a potential mechanism for sudden death in epilepsy

10.1161/circep.114.002693 · 2015 · External reference

Na+ currents are required for efficient excitation-contraction coupling in rabbit ventricular myocytes: a possible contribution of neuronal Na+ channels

10.1113/jphysiol.2010.194688 · 2010 · External reference

Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude

10.1161/hh0402.105177 · 2002 · External reference

Tubulin polymerization disrupts cardiac β-adrenergic regulation of late INa

10.1093/cvr/cvu120 · 2014 · External reference

Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation

10.1126/science.1185988 · 2010 · External reference

Caveolin-3 regulates compartmentation of cardiomyocyte beta2-adrenergic receptor-mediated cAMP signaling

10.1016/j.yjmcc.2013.12.003 · 2014 · External reference

State-dependent trapping of flecainide in the cardiac sodium channel

10.1113/jphysiol.2004.065003 · 2004 · External reference

An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart

10.1073/pnas.261705699 · 2002 · External reference

Electrophysiological properties of two axonal sodium channels, Nav1.2 and Nav1.6, expressed in mouse spinal sensory neurones

10.1113/jphysiol.2005.083089 · 2005 · External reference

Functional properties and differential neuromodulation of Na(v)1.6 channels

10.1016/j.mcn.2008.05.009 · 2008 · External reference

Mass spectrometry-based identification of native cardiac Nav1.5 channel α subunit phosphorylation sites

10.1021/pr300702c · 2012 · External reference

Suppression of spontaneous ca elevations prevents atrial fibrillation in calsequestrin 2-null hearts

10.1161/circep.113.000994 · 2014 · External reference

Recent advances in the molecular pathophysiology of atrial fibrillation

10.1172/jci46315 · 2011 · External reference

Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity

10.1161/circresaha.111.247338 · 2011 · External reference

“Ryanopathy”: causes and manifestations of RyR2 dysfunction in heart failure

10.1093/cvr/cvt024 · 2013 · External reference

Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments

10.1161/01.cir.84.3.1364 · 1991 · External reference

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

10.1056/nejm199103213241201 · 1991 · External reference

Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum

10.1152/ajpcell.1983.245.1.c1 · 1983 · External reference